BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wielpütz MO, Eichinger M, Puderbach M. Magnetic resonance imaging of cystic fibrosis lung disease. J Thorac Imaging 2013;28:151-9. [PMID: 23545948 DOI: 10.1097/RTI.0b013e31828d40d4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Cleveland RH, Sawicki GS, Stamoulis C. Similar performance of Brasfield and Wisconsin scoring systems in young children with cystic fibrosis. Pediatr Radiol 2015;45:1624-8. [DOI: 10.1007/s00247-015-3380-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Renz DM, Dohna M, Böttcher J, Kaireit TF, Pfeil A, Streitparth F, Vogel-claussen J. Magnetresonanztomographie der Lunge bei zystischer Fibrose. Monatsschr Kinderheilkd 2020;168:406-15. [DOI: 10.1007/s00112-020-00890-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ciet P, Serra G, Andrinopoulou ER, Bertolo S, Ros M, Catalano C, Colagrande S, Tiddens HA, Morana G. Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging. Eur Radiol 2016;26:3830-9. [PMID: 26873494 DOI: 10.1007/s00330-016-4248-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
4 Ranganathan SC, Hall GL, Sly PD, Stick SM, Douglas TA; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? Am J Respir Crit Care Med 2017;195:1567-75. [PMID: 27911585 DOI: 10.1164/rccm.201606-1107CI] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
5 Tümmler B. Mutation-specific therapy in cystic fibrosis: the earlier, the better. Lancet Respir Med 2013;1:591-2. [PMID: 24461654 DOI: 10.1016/S2213-2600(13)70186-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Dobra R, Edmondson C, Hughes D, Martin I, Davies JC. Potentiators and Correctors in Paediatric Cystic Fibrosis Patients: A Narrative Review. Paediatr Drugs 2018;20:555-66. [PMID: 30328089 DOI: 10.1007/s40272-018-0315-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, Kiessling F, Lammers T. Fibrosis imaging: Current concepts and future directions. Adv Drug Deliv Rev 2017;121:9-26. [PMID: 29108860 DOI: 10.1016/j.addr.2017.10.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 12.6] [Reference Citation Analysis]
8 Flors L, Mugler JP 3rd, de Lange EE, Miller GW, Mata JF, Tustison N, Ruset IC, Hersman FW, Altes TA. Hyperpolarized Gas Magnetic Resonance Lung Imaging in Children and Young Adults. J Thorac Imaging 2016;31:285-95. [PMID: 27428024 DOI: 10.1097/RTI.0000000000000218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Biederer J, Wielpütz MO, Jobst BJ, Dinkel J. [MRI of interstitial lung diseases: what is possible?]. Radiologe 2014;54:1204-12. [PMID: 25503519 DOI: 10.1007/s00117-014-2738-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
10 Wielpütz MO, Heußel CP, Herth FJ, Kauczor HU. Radiological diagnosis in lung disease: factoring treatment options into the choice of diagnostic modality. Dtsch Arztebl Int 2014;111:181-7. [PMID: 24698073 DOI: 10.3238/arztebl.2014.0181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]